Screener
Universal Health Services UHS Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 11.4%+0.4pp | 11.5%+0.6pp | 11.5%+0.9pp | 11.5%+1.5pp | 11%+1.4pp | |
| Net margin | 8.4%+0.8pp | 8.6%+1.1pp | 8.6%+1.4pp | 8.1%+1.4pp | 7.7%+1.4pp | |
| Returns | ||||||
| Return on equity | 21%+2.3pp | 21.3%+3.0pp | 21.4%+3.5pp | 20%+3.8pp | 18.7%+3.8pp | |
| Return on invested capital | 12.8%+0.8pp | 12.9%+1.3pp | 12.7%+1.4pp | 12.6%+2.1pp | 12%+2.0pp | |
| Efficiency | ||||||
| Asset turnover | 1.2×0.0× | 1.2×+0.1× | 1.2×0.0× | 1.1×+0.1× | 1.1×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.1×-0.2× | 1.1×-0.2× | 1.1×-0.2× | 1×-0.4× | 1.3×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.7×0.0× | 0.7×-0.1× | 0.7×0.0× | 0.7×-0.1× | 0.7×-0.1× | |
| Net debt / EBITDA | 1.9×-0.1× | 1.9×-0.2× | 2×-0.2× | 2×-0.4× | 2×-0.4× | |
| Per Share | ||||||
| Book value per share | $125.42+15.9% | $121.05+17.8% | $112.87+15.0% | $112.62+16.1% | $108.17+13.3% | |
| Valuation | ||||||
| Market capitalization | $10.32B-21.1% | $10.93B-10.5% | $13.62B+15.1% | $13.01B-15.1% | $11.29B-9.2% | |
| Price / earnings | 6.8×-2.7× | 7.2×-3.0× | 9.2×-1.2× | 9.5×-5.5× | 9×-4.3× | |
| Price / sales | 0.6×-0.2× | 0.6×-0.1× | 0.8×0.0× | 0.8×-0.2× | 0.7×-0.1× | |
| Price / book | 1.4×-0.5× | 1.5×-0.3× | 1.9×+0.1× | 1.8×-0.5× | 1.6×-0.3× | |
| EV / EBITDA | 5.7×-1.4× | 6×-1.4× | 7.2×-0.2× | 7.1×-2.5× | 6.7×-1.9× | |
| Dividend yield | 0.5%+0.1pp | 0.5%0.0pp | 0.4%-0.1pp | 0.4%0.0pp | 0.5%0.0pp |
FAQ
- Where do Universal Health Services's ratios come from?
- Every ratio is computed from Universal Health Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
